Biotech innovation doesn’t happen in a vacuum. Behind every successful molecule reaching clinical trials is a seamless CMC strategy ensuring regulatory approval, scalable production, and financial viability. At 3Biotech, we provide biotech start-ups with the expertise to optimize their development—often behind the scenes but always with a significant impact.
The quiet powerhouse behind CMC pharmaceutical development projects
In 2024 alone, 3Biotech has been instrumental in driving success for 92 pharmaceutical development projects. Our expertise spans across:
10 molecules advancing through Phase 1
4 molecules progressing to Phase 2
2 molecules nearing market approval in Phase 3
97% customer satisfaction, reflecting our commitment to executional excellence
While confidentiality prevents us from naming names, these figures demonstrate the sheer scale and impact of 3Biotech’s work. Every milestone reached, every regulatory hurdle cleared, and every optimization implemented translates into faster, more efficient drug development.
Maximising ROI in CMC pharmaceutical and biotech development
Early-stage biotech often operate under constrained resources, making efficiency and ROI critical. At 3Biotech, our expertise translates directly into measurable financial impact. Here are just a few examples of how we generate value:
4,000% ROI — Optimizing monoclonal antibody (mAb) productivity
Increasing titers from 0.5 g/L to 5.3 g/L results in massive cost savings per batch.
250% ROI — Scaling manufacturing efficiently
Transitioning from a 2,000L bioreactor to a 200L one while maintaining yield saved our client €1.6M.
1,500% ROI — Accelerating first-in-human trials
Reducing CMC development from 18 to 12 months allowed for €3M in additional market opportunities.
1,000% ROI — De-risking regulatory submissions
Securing first-time approval prevented costly delays and extra regulatory burdens.
Why early-stage biotech need 3Biotech for CMC strategy development
For early-stage biotech, time and resources are critical. A single misstep in CMC strategy or regulatory submission can set a project back by months or even years. 3Biotech provides proactive, expert-driven solutions to help companies anticipate challenges before they arise, ensuring that promising molecules advance swiftly and efficiently through development.
Confidential excellence in biotech consulting - our impact speaks for itself
3Biotech may not be a household name (yet), but our results speak volumes. Our specialist team works diligently behind the scenes, delivering high-value, high-impact solutions to biotech innovators who rely on our expertise to transform ground-breaking science into real-world therapeutics.
For early-stage biotech companies looking to accelerate development, optimise processes, and maximise returns, 3Biotech is the silent partner that makes all the difference.
Ready to unlock the full potential of your biotech development? Let’s talk.
Book a consultation today and see how 3Biotech can accelerate your path to market -with precision, efficiency, and compliance.